Study of HS235 for pulmonary arterial hypertension in adults
Part of Lungs & breathing clinical trials.
This trial tests an experimental drug called HS235 for people with pulmonary arterial hypertension (PAH), a condition of high blood pressure in the lungs. It aims to see if the drug can help improve symptoms and exercise ability.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- Your body mass index is between 18.5 and 40, and you weigh 120 kg (about 265 lbs) or less.
- You have a confirmed diagnosis of PAH (WHO Group 1) and are in functional class II to IV, meaning you have symptoms like shortness of breath but are not bedridden.
- You are currently taking at least 2 approved PAH medications and diuretics (water pills) at stable doses.
- You can walk between 150 meters (about 164 yards) and 500 meters (about 547 yards) in 6 minutes.
- You do not have any other type of pulmonary hypertension (like from heart or lung disease), recent major surgery, or serious heart or lung conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called NS-863 for people with pulmonary arterial hypertension (PAH), a condition of high blood pressure in the lungs. The study aims to see if the drug can improve symptoms and exercise ability.
This study tests whether using a mobile health tool can help people with pulmonary arterial hypertension (PAH) manage their condition in daily life. It’s aimed at adults who are stable on their PAH medicines and can track activity using a wearable device.
This study tests whether a home-based exercise program, added to your regular medications, can help people who are newly diagnosed with pulmonary arterial hypertension feel better and improve their daily function.
This study tests a new treatment called sotatercept for people with pulmonary arterial hypertension (PAH), a condition where the blood vessels in the lungs are narrow, making the heart work harder. The goal is to see if this medicine can help improve symptoms and daily function.
This trial tests a supervised exercise program for people with pulmonary arterial hypertension (PAH), a type of high blood pressure in the lungs. It aims to see if regular exercise can improve your daily function and quality of life.
This study tests an investigational drug (HS235) for people who have both heart failure with preserved ejection fraction and a type of pulmonary hypertension that can happen with it. The goal is to see if the drug can improve symptoms and quality of life.
Hear when a new Pulmonary Arterial Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.